Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease

BACKGROUND. Noninvasive detection of Alzheimer’s disease (AD) with high specificity and sensitivity can greatly facilitate identification of at-risk populations for earlier, more effective intervention. AD patients exhibit a myriad of retinal pathologies, including hallmark amyloid β-protein (Aβ) de...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCI Insight
Asıl Yazarlar: Koronyo, Yosef, Biggs, David, Barron, Ernesto, Boyer, David S., Pearlman, Joel A., Au, William J., Kile, Shawn J., Blanco, Austin, Fuchs, Dieu-Trang, Ashfaq, Adeel, Frautschy, Sally, Cole, Gregory M., Miller, Carol A., Hinton, David R., Verdooner, Steven R., Black, Keith L., Koronyo-Hamaoui, Maya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2017
Konular:
Clinical Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621887/
https://ncbi.nlm.nih.gov/pubmed/28814675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.93621
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller